Medical, biological, and pharmaceutical preparations for the treatment of cancer, infectious diseases, and rare and orphan diseases; Therapeutic preparations in the nature of vaccines or nucleic acid, protein or small-molecule medicines, delivered via intramuscular injections, intravenous injections, inhalation, transdermal, intradermal, or intranasal methods, for the treatment of cancer, infectious diseases, and rare and orphan diseases; Immunotherapeutics, namely, pharmaceutical preparations in the nature of vaccines and nucleic acid, protein or small-molecule medicines for the treatment of cancer, infectious diseases, and rare and orphan diseases; Nanoparticles and nanoparticle formulations in the nature of active pharmaceutical ingredient delivery agents in the form of nanoparticles that facilitate the delivery of medical, biological, pharmaceutical, and therapeutic preparations for the treatment of cancer, infectious diseases, and rare and orphan diseases; Pharmaceutical preparations, namely, lipid-enabled drug delivery systems for nucleic acid, protein or small-molecule medicines comprising small interfering RNA, messenger RNA, antisense, microRNA, DNA, or cDNA oligotherapeutic, protein therapeutic agents, or small molecules to enable the targeting of any gene in the human genome, modulating immune response, or vaccination, sold to pharmaceutical companies as an integral component for use in the further manufacture of pharmaceutical preparations for the treatment of a wide variety of diseases, including cancer, infectious diseases, and rare and orphan diseases; Vaccines; Veterinary vaccines
Pharmaceuticals